Ako Ishihara

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 5

Top Topics

Transforming Growth Factor

Dendritic Cells

Top Venues

Science advances

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jun Ishihara, Ako Ishihara, Koichi Sasaki, Steve Seung-Young Lee, John-Michael Williford, Mariko Yasui, Hiroyuki Abe, Lambert Potin, Peyman Hosseinchi, Kazuto Fukunaga, Michal M Rączy, Laura T Gray, Aslan Mansurov, Kiyomitsu Katsumata, Masashi Fukayama, Stephen J Kron, Melody A Swartz, Jeffrey A Hubbell
Targeted antibody and cytokine cancer immunotherapies through collagen affinity. Science translational medicine 11 (487) (2020)
Koichi Sasaki, Jun Ishihara, Ako Ishihara, Risako Miura, Aslan Mansurov, Kazuto Fukunaga, Jeffrey A Hubbell
Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy. Science advances 5 (8) (2019)
John-Michael Williford, Jun Ishihara, Ako Ishihara, Aslan Mansurov, Peyman Hosseinchi, Tiffany M Marchell, Lambert Potin, Melody A Swartz, Jeffrey A Hubbell
Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Science advances 5 (12) (2019)
Kiyomitsu Katsumata, Jun Ishihara, Aslan Mansurov, Ako Ishihara, Michal M Rączy, Eiji Yuba, Jeffrey A Hubbell
Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies. Science advances 5 (11) (2019)
Jun Ishihara, Kazuto Fukunaga, Ako Ishihara, Hans M Larsson, Lambert Potin, Peyman Hosseinchi, Gabriele Galliverti, Melody A Swartz, Jeffrey A Hubbell
Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events. Science translational medicine 9 (415) (2018)